Intrommune Therapeutics Supports Outcome of FDA Allergenic Product Advisory Committee Vote
September 16, 2019 14:25 ET
|
Intrommune Therapeutics
New York, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly immunotherapy platform for the treatment of peanut and...
DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against DBV Technologies S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
March 15, 2019 10:49 ET
|
Schall Law
LOS ANGELES, March 15, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against DBV Technologies S.A. (“DBV...
DBV MARCH 18 DEADLINE: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against DBV Technologies S.A. – DBVT
March 12, 2019 15:50 ET
|
Zhang Investor Law P.C.
NEW YORK, March 12, 2019 (GLOBE NEWSWIRE) -- Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of DBV Technologies S.A. (NASDAQ: DBVT)...
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against DBV Technologies S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
February 05, 2019 14:48 ET
|
Schall Law
LOS ANGELES, Feb. 05, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against DBV Technologies S.A. (“DBV...
IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against DBV Technologies S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
January 23, 2019 12:59 ET
|
Schall Law
LOS ANGELES, Jan. 23, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against DBV Technologies S.A. (“DBV...
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against DBV Technologies S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
January 03, 2019 10:45 ET
|
Schall Law
LOS ANGELES, Jan. 03, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DBV...
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against DBV Technologies S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
December 27, 2018 12:04 ET
|
Schall Law
LOS ANGELES, Dec. 27, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DBV...
Doubleview Capital Corp. (TSX-V:DBV) Closes Fully Subscribed Private Placement Financing
October 10, 2017 18:47 ET
|
Doubleview Capital Corp.
VANCOUVER, British Columbia, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Doubleview Capital Corp. (“Doubleview”) (TSX-V:DBV) (OTC PINK:DBLVF) (Frankfurt:1D4) is pleased to announce that it has closed its...